WO1997045592A1 - Schallschutzeinrichtung für gleise - Google Patents
Schallschutzeinrichtung für gleise Download PDFInfo
- Publication number
- WO1997045592A1 WO1997045592A1 PCT/AT1997/000109 AT9700109W WO9745592A1 WO 1997045592 A1 WO1997045592 A1 WO 1997045592A1 AT 9700109 W AT9700109 W AT 9700109W WO 9745592 A1 WO9745592 A1 WO 9745592A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plate
- plates
- partial
- soundproofing device
- support sections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- E—FIXED CONSTRUCTIONS
- E01—CONSTRUCTION OF ROADS, RAILWAYS, OR BRIDGES
- E01B—PERMANENT WAY; PERMANENT-WAY TOOLS; MACHINES FOR MAKING RAILWAYS OF ALL KINDS
- E01B19/00—Protection of permanent way against development of dust or against the effect of wind, sun, frost, or corrosion; Means to reduce development of noise
- E01B19/003—Means for reducing the development or propagation of noise
Definitions
- the invention relates to a soundproofing device for tracks, with sound-absorbing plates mounted on the rails of the track, which are supported on the rails by elastic profiles, the plates arranged between the rails cantilevering the space between the rails. Furthermore, the invention relates to sound-absorbing panels for such a soundproofing device.
- the plates arranged between the rails of the track consist of three layers or layers which are supported by elastic profiles on the rail foot, web and on the underside.
- the upper layer consists of steel wire fabric that can be walked on, the edge of which is glued, welded or vulcanized into the profile.
- the middle layer is designed as a sound absorption layer and consists of glass wool or rock wool. This sound absorption layer lies on the lower layer, which is designed as a perforated wall or grate and is supported in a recess in the profile in the region of the rail foot.
- the panels are also arranged on the outside of the rail and angled upward at the ends in order to form a lateral soundproofing wall.
- Such mineral wool panels have adequate sound absorption at high frequencies, but have inadequate sound absorption at low frequencies.
- a further disadvantage of this construction is that the walkable perforated wall made of steel wire mesh can detach itself from its anchoring in the profiles at higher and repeated loads, so that the sound absorption layer underneath can be damaged.
- the dust penetrating through the perforated wall can be deposited on the upper side of the sound absorption layer and thus the sound damping effect can deteriorate increasingly.
- the invention has for its object to provide a soundproofing device for tracks with sound-absorbing plates, which has good sound absorption or damping over the entire frequency range essential for the sound level of rail traffic, with a permanent mechanical Strength of the device should be guaranteed.
- the soundproofing device of the type mentioned at the outset in that the plates consist of particles of porous lightweight construction material which are joined together with a binder, and in that the plates have embedded reinforcement and are arranged uncovered.
- the airborne noise emanating in particular from the wheels of a rail vehicle and from the rails is absorbed on the surface of the plates by the pores of the particles and can also be selected if a structure is left that leaves fine spaces between the particles, via spaces or channels between the particles penetrate deeper into the plate to gradually be completely dampened there.
- the reinforcement of the panels also ensures that they can be walked on.
- the top of the plates is structured, and even better results can be achieved if the structuring is irregular.
- the top of the plates is preferably provided with ribs running parallel to the rails, which results in structuring that is simple to construct.
- the ribs have a trapezoidal cross-section, since this makes it easier to absorb obliquely incident sound waves.
- the wall of the cavity resonators and their sound openings are provided with a sound-absorbing structure, and / or if the wall of the cavity resonators and their tubular sound openings are provided with a sound-absorbing layer are provided.
- the cavities forming the cavity resonators are designed to be open at the bottom and are covered with a lower plate.
- the cavities forming the cavity resonators are designed to be open at the bottom and form a resonance cavity together with the track bedding.
- the damped resonance frequency of the cavity resonators is within a frequency range from 150 to 1000 Hz, preferably between 500 and 1000 Hz.
- a special embodiment is also provided in which the installation and removal of the plates to be provided between the two rails of a track can be accomplished in a very simple manner.
- This embodiment of the soundproofing device is characterized in that the space lying between the two rails of a track is bridged with partial plates arranged in pairs, each of which engages with at least one supporting rib in the link chambers of the rails, the partial plates of each pair of plates at their mutually facing edges are supported on one another and in this case support sections and support sections are provided alternately in a meandering manner on each section plate along the edge facing the other section plate, the support sections being formed by depressions extending from the top of the plate and facing the other section plate and under the support sections from the underside of the plate, upward depressions are formed, which are complementary to the depressions of the support sections, and the support sections of a partial plate on the support sections the other partial plate and the support sections of the other partial plate rest on the supporting sections of the one partial plate.
- the zones of the partial plates of each pair of plates to be joined in an articulated manner can simply be plugged together when the partial plates are unfolded, after which the partial plates can be inserted between the rails without problems by leveling the pair of plates, and the partial plates also become Loads not pushed apart.
- a preferred type of the last-mentioned embodiment which is characterized in that projections and recesses shaped complementarily to the projections, into which the projections engage, are provided on those surfaces on which the partial plates of a pair of plates abut one another, for mutual locking of the partial plates, offers the advantage that the cohesion of the partial plates of a pair of plates is ensured even over very long periods of time even when unfavorable vibrations act on the partial plates.
- Such a crowning can be formed on a partial plate by a surface section which extends from the edge facing the other partial plate of the pair of plates and extends away from the underside of the plate, and a subsequent surface section which approaches the underside of the plate. If one wishes to additionally provide a latching in such a configuration of the partial plates, it is advantageous if they are designed in such a way that projections pointing downward are provided on the end edges of the supporting sections and recesses complementary to these projections are provided on the supporting surfaces of the supporting sections.
- An embodiment which is particularly favorable for the course of the leveling process when installing the partial plates and for achieving the most stable possible position of the two partial plates of a pair of plates relative to one another in the installed state characterized in that the cambered shaped wings are shaped according to a toothing which, up to the leveled position of the partial plates of the respective pair of plates, enables sliding or rolling movement of the facing wings and supporting surfaces towards one another and in the leveled position of these partial plates against one another Movement of these partial plates to each other blocks.
- the reinforcement provided in the sub-panels extends over the panel surface and engages in the supporting sections and in the supporting sections and in the supporting ribs. It is also advantageous if one provides that an elastic or / or shock-absorbing insert or coating is provided between the wings provided on the support sections and the support surfaces provided on the support sections.
- a sound-absorbing plate according to the invention is characterized in that the plate consists of particles made of porous lightweight material, which are joined together with a binder, that the plate has an embedded reinforcement, and that in the plate cavity resonators with a large area of the Plate directed tubular sound openings are formed, which large area to form the top is provided when installing the plate in the track. It is advantageous here if the cavities forming the cavity resonators are designed to be open and widening towards the large area that lies on the side of the plate facing away from the tubular sound openings. A further development is characterized in that the cavities forming the cavity resonators are covered with a lower plate on the side facing away from the tubular sound openings.
- Embodiments of a plate designed according to the invention which are provided for the aforementioned formation with partial plates to be joined to form a pair of plates, are characterized in that the plate consists of particles of porous lightweight building material, which are joined together with a binder, so that the plate is an embedded one Reinforcement has that the plate is provided on one edge side with a support rib for engaging in the tab chambers of rails and on the edge side opposite this support rib has meandering succession of support sections and support sections, the support sections extending from the top of the plate and depressions extending to the edge are formed and under the support sections, from the underside of the plate, upward depressions are formed, which are complementary to the depressions of the support sections.
- cavity resonators are formed in the plate with tubular sound openings directed towards a large area of the plate, which large area is provided for forming the upper side when the plate is installed in the track. It is also advantageous here if the reinforcement provided in the plate extends over the entire surface of the plate and extends into the support sections and into the support sections and into the support rib. If desired, the plates or partial plates can also be provided with a frame running along the edge, preferably consisting of metal or fiber-reinforced plastic.
- FIG. 1 shows a plan view of a track with sound-absorbing plates arranged between the rails
- FIG. 2 shows a section along the line II-II in Fig.l
- 3 shows an embodiment of a plate in cross section
- FIG. 4 shows an enlarged detail of the surface of the plate according to FIG. 2 or 3;
- FIG. 5 shows an embodiment of a soundproofing device designed according to the invention with partial plates in a top view
- FIG. 10 shows a variant with regard to the design of the support sections and the support sections in a sectional representation corresponding to FIG. 7,
- FIG. 11 shows another embodiment of a soundproofing device designed according to the invention with partial panels, in a top view
- FIG. 16 shows a variant with regard to the design of the support sections and the support sections of the partial plates in a sectional representation corresponding to FIG. 13.
- sound-absorbing plates 3 are arranged next to one another in the longitudinal direction of the track between the rails 2.
- the generally rectangular plates 3 have, on their two edges along the rails 2, projecting support ribs 4, which are interposed with elastic profiles 5, for example made of rubber or elastomer, support on the rail base 6, on the rail web 7 and on the underside of the rail head 8 of the rails 2.
- the plates 3, the surface of which is shown enlarged in FIG. 4, consist of particles 9 made of porous lightweight material, which are joined together with a suitable binder.
- Plastic granulate, granular or spherical and fired alumina particles, granular slag particles, or similar fired natural or artificially produced materials are used as the lightweight construction material, these particles being selectively connected with a suitable plastic binder or cement, so that small spaces or channels 10 remain, which allow air ducting and drainage of penetrating rain or melt water.
- the panels 3 are provided with a reinforcement 11, for example made of steel or other metals, fiber-reinforced plastic, glass fiber mats or the like.
- the surface of the plates 3 can be increased by structuring.
- the top 12 of the plates 3 can be provided with ribs 13 which run parallel to the rails 2 and are spaced apart from one another and which, as shown in FIG. 3, have a trapezoidal cross section and a height a above the rail head 8 which are closed ⁇ not exceeding 5 cm.
- the structure can also be irregular, for example by increasing or decreasing the spacing of the ribs 13 from one another.
- a structuring of the top 12 for example, truncated cones, truncated pyramids, cylinders, cuboids, etc. can also be provided, which are arranged either at the same or at different distances from one another.
- 3 cavity resonators 14 in the manner of the Helmholz resonator are formed in the plates, the tubular sound openings of which 15 are provided on the top 12 of the plates 3.
- the cavities forming the cavity resonators 14 are frustoconical and open at the bottom, the openings formed thereby being covered by a sub-plate 16, for example glued to the plate 3, in order to form the cavity resonator 14 .
- the cavities forming the cavity resonators 14 can also be designed to deviate from the shape of a truncated cone, for example spherical, cylindrical, pyramid-shaped, etc., in order to achieve a different frequency behavior in the case of sound absorption.
- the volumes of the cavity resonators 14 and the dimensions of the tubular sound openings can be varied in order to achieve the desired frequency behavior or frequency absorption spectrum. As shown in FIG.
- the tubular sound openings 15 open perpendicular to the top 12 of the plate 3.
- the tubular sound openings 15 can also open at an angle to the top 12 of the plates 3 in order to be able to better absorb obliquely incident sound waves .
- the plates 3 with the cavity resonators 14 can be produced in a rectangular shape in which positive shapes of the cavity resonators with attached pipe pieces for the sound openings are used, whereupon the mold is filled with the particles 9 and a binder and demolded after the binder has hardened becomes.
- Prefabricated cavity resonators with attached pipe pieces as sound openings can also be used as positive forms, which either consist of a suitable sound-absorbing material or are provided on the inside with a layer of sound-absorbing material.
- sound-absorbing plates with cavity resonators can also be provided on the outside of the rails 2.
- the plate 18 shown in dash-dotted lines on the right rail 2 is at one End, similar to the plate 3 lying between rails 2, is supported on the rail 2 via an elastic profile 5 and at the other end via an elastic strip 19 and fixed by means of a fastening element, in particular a screw 20.
- the plate 21 on the left rail 2, also shown with a dash-dotted line, is supported and fixed in the same way as the plate 18, but has an end region that is angled upwards on the outside in order to form a soundproofing wall.
- the two plates 18, 21 likewise have reinforcement (not shown) and, if appropriate, a structure in the form of ribs (not shown). If desired, the plates can also be provided with a frame running along the edge.
- the space 22 lying between the two rails 2 of a track 1 is filled or bridged with paired sound-absorbing partial plates 3a, 3b.
- These sub-plates 3a, 3b have support ribs 4 which engage in the tab chambers 23 of the rails 2, and elastic profiles 5 with an approximately C-shaped cross section are inserted between the support ribs 4 and the rails 2.
- the partial plates 3a, 3b are supported with their supporting ribs 4 on the rail foot 6 and laterally against the rail web 7 and held upwards by engagement under the rail head 8.
- the partial plates 3a, 3b bridge the distance 24 between the rails 2 in a self-supporting manner.
- a plurality of support ribs 4 are provided on each of the partial plates 3a, 3b, which are arranged at a distance from one another in order to leave the fastening elements 25 provided for the rails 2 accessible.
- each pair of plates are supported on one another, so that each pair of plates forms an assembled body which bridges the distance 24 between the rails 2 in a self-supporting manner.
- the support sections 28 being formed by depressions 30 which extend from the top side 12 of the plate and extend to the edge facing the other partial plate; under the support sections 29, starting from the lower side 31 of the plate, upward depressions 32 are formed, and the support sections of the partial plate 3a lie on the supporting sections of the partial plate 3b and the supporting sections of the partial plate 3b rest on the supporting sections of the partial plate 3a;
- the depressions 30 are complementary to the depressions 32, so that the support surfaces 34 formed on the support sections 29 by the depressions 32 lie substantially snugly on the support surfaces 33 formed by the depressions 30 on the support sections 28.
- the partial plates 3a, 3b In order to insert the partial plates 3a, 3b in pairs between the rails 2 of a track, they can first be arranged in the unfolded position, as shown in FIG. 9, and in the process they can be inserted into one another with their meandering edges 26, 27 also arranges the elastic profiles 5, which have a C-shaped cross section, between the supporting ribs 4 of the partial plates 3a, 3b and the rails 2. Then the partial plates 3a, 3b are pivoted or folded down, as indicated by the arrow 35, until they assume the leveled position shown in FIGS. 5 to 7, in which the partial plates 3a, 3b of each pair of plates space 22 between bridge the rails 2 in a self-supporting manner.
- the support surfaces 33 provided in the support sections 28 have a cambered shape, and there is such a cambered shape also in the support surfaces 34 provided on the support sections 29, and this cambered shape of the named surfaces ensures that the partial plates retain their shape 3a, 3b create ge, which in the leveled position of the partial plates 3a, 3b inhibits a mutual movement of these partial plates in the direction of the plate plane (arrows 36).
- projections 37 are provided on the support surfaces 34 and recesses 38 are provided on the support surfaces 33, which are complementary to the projections 37; in the leveled position of the partial plates, the Projections 37 into the recesses 38, so that there is a mutual locking of the partial plates 3a, 3b.
- an elastic and / or shock-absorbing insert or coating can be provided between the support surfaces 33 and the support surfaces 34.
- the supporting surfaces 33 provided on the supporting sections run, starting from the edge 26 or 27 of the respective partial plate 3a or 3b, first rising steeply from the underside 31 of the plate and then becoming flatter, which is advantageous for joining the partial plates to the pairs of plates. From a geometrical point of view, it is favorable if such domed wings are shaped according to a toothing which, up to the leveled position of the partial plates 3a, 3b of the respective plate pair, enables a sliding movement or rolling movement of the mutually facing wings and supporting surfaces on one another, and in the leveled position (Fig. 5 to 7) locks these partial plates against movement to each other.
- This geometrical shape corresponding to a toothing can extend up to the top 12 of the plate.
- the projections 37 can, as shown in FIGS. 5 to 8, be provided on the end edges 39 of the support sections 29, which can bring advantages when joining the partial plates, but it is also possible to place such projections 37 elsewhere, e.g. slightly removed from the edge of the support surfaces.
- the support surfaces 33 and the support surfaces 34 are largely flat; In this case, too, recesses 38, into which projections 37 engage, are provided for mutual locking of the partial plates 3a, 3b.
- the two partial plates 3a, 3b of a pair of plates lie on one another in a meandering manner on the underside 31 of the plate, so that the mutually facing edges of the partial plates 3a , 3b run on the underside of the plate following a meandering line 43. This results in a very intimate cohesion of the partial plates 3a, 3b forming a pair of plates.
- the partial plates 3a, 3b are rounded at the mutually facing edges 26, 27 from the underside 31 of the plate upwards, the radius of curvature of this rounding being equal to or smaller than the distance 41 between the edges 26, 27 and the rail-side edges 42 of the partial plates 3a, 3b. This measure is also advantageous for an unrestrained process of inserting the partial plates.
- the reinforcement 11 provided in the partial plates extends over the entire surface extent of the partial plates 3a, 3b and, as indicated by the broken lines in FIG. 8, both in the support sections 28 and in the support sections 29 as well engages in the support ribs 4.
- cavity resonators 14 with sound openings 15 can be provided, as is the case e.g. 11 to 14 is shown.
- the plates can also be provided with frames 44, as is e.g. is indicated by dashed lines in FIG.
Landscapes
- Engineering & Computer Science (AREA)
- Architecture (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Building Environments (AREA)
- Soundproofing, Sound Blocking, And Sound Damping (AREA)
- Railway Tracks (AREA)
- Power-Operated Mechanisms For Wings (AREA)
- Devices Affording Protection Of Roads Or Walls For Sound Insulation (AREA)
- Bridges Or Land Bridges (AREA)
- Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
- Signal Processing Not Specific To The Method Of Recording And Reproducing (AREA)
- Noise Elimination (AREA)
- Magnetic Heads (AREA)
- Holo Graphy (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP54125697A JP3822641B2 (ja) | 1996-05-29 | 1997-05-23 | 軌道用の防音装置 |
| US09/194,505 US6253872B1 (en) | 1996-05-29 | 1997-05-23 | Track soundproofing arrangement |
| EP97922748A EP0901536B1 (de) | 1996-05-29 | 1997-05-23 | Schallschutzeinrichtung für gleise |
| DK97922748T DK0901536T3 (da) | 1996-05-29 | 1997-05-23 | Støjdæmpningsindretning til spor |
| AU28801/97A AU738889B2 (en) | 1996-05-29 | 1997-05-23 | A noise control device for tracks |
| HU9903612A HU221872B1 (hu) | 1996-05-29 | 1997-05-23 | Zajvédelmi berendezés vasúti vágányokhoz |
| AT97922748T ATE229595T1 (de) | 1996-05-29 | 1997-05-23 | Schallschutzeinrichtung für gleise |
| DE59708955T DE59708955D1 (de) | 1996-05-29 | 1997-05-23 | Schallschutzeinrichtung für gleise |
| CA002255946A CA2255946C (en) | 1996-05-29 | 1997-05-23 | Track soundproofing arrangement |
| SI9730491T SI0901536T1 (en) | 1996-05-29 | 1997-05-23 | Track soundproofing arrangement |
| NO19985600A NO316078B1 (no) | 1996-05-29 | 1998-11-30 | Lydisoleringsanordning for skinnespor, samt en lydabsorberende plate for denne |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT93496A AT403809B (de) | 1996-05-29 | 1996-05-29 | Schallschutzeinrichtung für gleise |
| ATA934/96 | 1996-05-29 | ||
| AT0101596A AT405426B (de) | 1996-06-11 | 1996-06-11 | Schienengleiche eindeckung für gleise |
| ATA1015/96 | 1996-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1997045592A1 true WO1997045592A1 (de) | 1997-12-04 |
Family
ID=25594370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/AT1997/000109 Ceased WO1997045592A1 (de) | 1996-05-29 | 1997-05-23 | Schallschutzeinrichtung für gleise |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6253872B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP0901536B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3822641B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN100424268C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE229595T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU738889B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2255946C (cg-RX-API-DMAC7.html) |
| DE (1) | DE59708955D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0901536T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2186891T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HU221872B1 (cg-RX-API-DMAC7.html) |
| NO (1) | NO316078B1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW345603B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1997045592A1 (cg-RX-API-DMAC7.html) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0945547A1 (de) * | 1998-03-21 | 1999-09-29 | Johann Rath | Vorrichtung zur Dämpfung von Schallemissionen an Gleisanlagen |
| EP1039032A1 (de) * | 1999-03-26 | 2000-09-27 | DVG Deutsche Verpackungsmittel-GmbH | Absorptionsbelag zur Reduzierung der Schallabstrahlung für Gleiskörper |
| US6481637B1 (en) * | 2000-11-20 | 2002-11-19 | Mcqueen Philip Jeffrey | Rail pad and method for strain attentuation |
| WO2005085529A1 (de) * | 2004-03-05 | 2005-09-15 | Gmundner Fertigteile Gesellschaft M.B.H. & Co. Kg. | Störschall mindernde gleiseindeckung |
| NL2003697C2 (nl) * | 2009-10-22 | 2011-04-26 | Univ Twente | Weg met geluid-diffractoren. |
Families Citing this family (311)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
| DE10111919A1 (de) * | 2001-03-13 | 2002-09-19 | Boegl Max Bauunternehmung Gmbh | Fahrwegträger |
| HU224236B1 (hu) * | 2001-12-14 | 2005-06-28 | Attila Szebeni | Vasúti acélhidaknál alkalmazható, egymáshoz csatlakoztatott elemekbõl álló, zaj- és rezgéscsökkentett mûanyag járólemezrendszer |
| US8829198B2 (en) | 2007-10-31 | 2014-09-09 | Proteotech Inc | Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies |
| WO2004002476A2 (en) | 2002-06-27 | 2004-01-08 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| US7053210B2 (en) | 2002-07-02 | 2006-05-30 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its derivatives |
| AT6414U1 (de) * | 2002-07-17 | 2003-10-27 | Gmundner Fertigteile Gmbh | Gleisabdeckung |
| GB2399123B (en) * | 2003-03-05 | 2006-03-01 | Corus Uk Ltd | Rail damper |
| US20040242886A1 (en) * | 2003-04-30 | 2004-12-02 | Sandeep Gupta | Monocyclic diazodioxide based Bcl-2 protein antagonists related applications |
| US20040248877A1 (en) * | 2003-04-30 | 2004-12-09 | Sandeep Gupta | Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof |
| CN102584813B (zh) * | 2003-05-14 | 2016-07-06 | Ngc药物公司 | 化合物及其在调节淀粉样蛋白β中的用途 |
| US8916598B2 (en) | 2003-05-30 | 2014-12-23 | Proteotech Inc | Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies |
| US20100331380A1 (en) * | 2009-06-29 | 2010-12-30 | Esposito Luke A | Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
| WO2005090370A1 (en) * | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
| US8616331B2 (en) | 2004-02-12 | 2013-12-31 | Eric C. Humphries | Panel assembly for traffic noise barrier wall |
| US20100126797A1 (en) * | 2004-02-12 | 2010-05-27 | Humphries Eric C | Panel Assembly For Traffic Noise Barrier Wall |
| US7546900B2 (en) * | 2004-02-12 | 2009-06-16 | Evonik Cyro Llc | Panel assembly for traffic noise barrier wall |
| WO2005112913A1 (en) | 2004-05-20 | 2005-12-01 | The Scripps Research Institute | Transthyretin stabilization |
| ATE531367T1 (de) | 2004-09-17 | 2011-11-15 | Whitehead Biomedical Inst | Verbindungen, zusammensetzungen und verfahren zur verhinderung einer a-synuklein-vergiftung |
| US20060067889A1 (en) * | 2004-09-27 | 2006-03-30 | Light Sciences Corporation | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents |
| US20070131480A1 (en) * | 2004-12-06 | 2007-06-14 | Corbin Maxwell H Jr | Sound arresting barrier |
| US7464791B2 (en) * | 2005-01-27 | 2008-12-16 | Pretty Products, Llc | Acoustic mats and methods for making the same |
| US20060230699A1 (en) * | 2005-03-22 | 2006-10-19 | Keene James R | Sound control flooring systems and methods therefor |
| US20090156545A1 (en) * | 2005-04-01 | 2009-06-18 | Hostetler Karl Y | Substituted Phosphate Esters of Nucleoside Phosphonates |
| JP5242375B2 (ja) | 2005-04-01 | 2013-07-24 | ザ レゲントス オブ ザ ユニバーシティ オブ カリフォルニア | ホスホノ−ペント−2−エン−1−イルヌクレオシド及び類似体 |
| WO2008051197A2 (en) * | 2005-09-20 | 2008-05-02 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| WO2007076160A2 (en) * | 2005-12-28 | 2007-07-05 | Acidophil Llc | C-10 carbamates of taxanes |
| AU2007225088B2 (en) | 2006-03-13 | 2012-09-13 | Kyorin Pharmaceutical Co., Ltd | Aminoquinolones as GSK-3 inhibitors |
| US20100273776A1 (en) * | 2006-03-29 | 2010-10-28 | FOLDRx PHARMACEUTICALS, INC | Inhibition of alpha-synuclein toxicity |
| AU2007260579B2 (en) * | 2006-06-13 | 2012-09-06 | Newstyle Nominees Pty Ltd | Rail track crossing |
| EP2484696B1 (en) | 2006-08-28 | 2017-08-16 | Kyowa Hakko Kirin Co., Ltd. | Antagonistic hLIGHT-specific human monoclonal antibodies |
| MX2009002960A (es) | 2006-09-21 | 2009-06-26 | Activx Biosciences Inc | Inhibidores de serina hidrolasa. |
| WO2008049116A2 (en) | 2006-10-19 | 2008-04-24 | Auspex Pharmaceuticals, Inc. | Substituted indoles |
| JP5013590B2 (ja) * | 2006-11-14 | 2012-08-29 | エンデバーハウス株式会社 | 伸縮性に優れた線路用吸音材 |
| US20080146605A1 (en) | 2006-12-19 | 2008-06-19 | Auspex Pharmaceuticals, Inc. | Preparation and utility of ccr5 inhibitors |
| CN101611008A (zh) * | 2006-12-22 | 2009-12-23 | 恩希赛弗制药公司 | C3a受体调节剂及其使用方法 |
| WO2008106167A1 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases |
| WO2008106166A2 (en) | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Methods for the treatment of liver diseases using specified matrix metalloproteinase (mmp) inhibitors |
| CA2680912C (en) | 2007-03-15 | 2017-11-14 | Auspex Pharmaceuticals, Inc. | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| US7892776B2 (en) | 2007-05-04 | 2011-02-22 | The Regents Of The University Of California | Screening assay to identify modulators of protein kinase A |
| JP2010533205A (ja) * | 2007-07-12 | 2010-10-21 | トラガラ ファーマシューティカルズ,インク. | 癌、腫瘍、および腫瘍関連障害を治療するための方法および組成物 |
| CA2699151A1 (en) * | 2007-09-11 | 2009-03-19 | Activx Biosciences, Inc. | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| KR101597841B1 (ko) | 2007-09-12 | 2016-02-26 | 교린 세이야꾸 가부시키 가이샤 | Gsk-3 억제제로서의 스피로시클릭 아미노퀴놀론 |
| US20090264421A1 (en) * | 2007-10-05 | 2009-10-22 | Bible Keith C | Methods and Compositions for Treating Cancer |
| US8353464B2 (en) * | 2007-11-07 | 2013-01-15 | Wai Lun Ho | Tunable vibration absorbing device |
| US8426587B2 (en) * | 2007-11-21 | 2013-04-23 | Pharmaxis Ltd. | Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor |
| WO2009111611A2 (en) * | 2008-03-05 | 2009-09-11 | Proteotech Inc. | Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes |
| AU2009226136B2 (en) | 2008-03-17 | 2013-08-15 | Ambit Biosciences Corporation | Quinazoline derivatives as RAF kinase modulators and methods of use thereof |
| US20110070154A1 (en) * | 2008-08-13 | 2011-03-24 | Hyde Roderick A | Artificial cells |
| CN101658533A (zh) * | 2008-08-29 | 2010-03-03 | 首都医科大学宣武医院 | 抗肿瘤药物的干细胞递送 |
| US8048204B2 (en) * | 2008-09-23 | 2011-11-01 | Rwdi Air Inc. | Wall assembly |
| WO2010088450A2 (en) | 2009-01-30 | 2010-08-05 | Celladon Corporation | Methods for treating diseases associated with the modulation of serca |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| CA2752885A1 (en) | 2009-02-27 | 2010-09-02 | Ambit Biosciences Corporation | Jak kinase modulating quinazoline derivatives and methods of use thereof |
| WO2010101967A2 (en) | 2009-03-04 | 2010-09-10 | Idenix Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole hcv polymerase inhibitors |
| US8146310B2 (en) * | 2009-03-11 | 2012-04-03 | Keene Building Products Co., Inc. | Noise control flooring system |
| CA2755120C (en) * | 2009-03-11 | 2017-05-16 | Kyorin Pharmaceutical Co., Ltd. | 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| JP2012520314A (ja) | 2009-03-11 | 2012-09-06 | アムビト ビオスシエンセス コルポラチオン | 癌治療のためのインダゾリルアミノピロロトリアジンとタキサンの併用 |
| WO2010110686A1 (en) | 2009-03-27 | 2010-09-30 | Pathway Therapeutics Limited | Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy |
| CA2756067A1 (en) | 2009-03-27 | 2010-09-30 | Pathway Therapeutics, Inc. | Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| KR101687144B1 (ko) | 2009-04-22 | 2016-12-15 | 액시킨 파마수티컬스 인코포레이티드 | 2,5-이치환된 아릴설폰아마이드 ccr3 길항제 |
| CN102459210B (zh) | 2009-04-22 | 2015-09-02 | 埃克希金医药品有限公司 | 芳基磺酰胺ccr3拮抗剂 |
| EP2727908A3 (en) | 2009-04-22 | 2014-08-20 | Axikin Pharmaceuticals, Inc. | 2,5-disubstituted arylsulfonamide CCR3 antagonists |
| WO2011003870A2 (en) | 2009-07-06 | 2011-01-13 | Creabilis S.A. | Mini-pegylated corticosteroids, compositions including same, and methods of making and using same |
| CA2767008C (en) | 2009-07-07 | 2018-01-30 | Pathway Therapeutics, Inc. | Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| JP5905387B2 (ja) | 2009-07-08 | 2016-04-20 | ホープ メディカル エンタープライゼズ,インコーポレイテッド ディービーエー ホープ ファーマシュティカルズHope Medical Enterprises,Inc.Dba Hope Pharmaceuticals | チオ硫酸ナトリウムを含有する薬学的組成物 |
| US8404728B2 (en) | 2009-07-30 | 2013-03-26 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| AR077712A1 (es) | 2009-08-05 | 2011-09-14 | Idenix Pharmaceuticals Inc | Inhibidores de serina proteasa macrociclica |
| KR20120059558A (ko) | 2009-08-19 | 2012-06-08 | 암비트 바이오사이언시즈 코포레이션 | 바이아릴 화합물 및 이의 사용 방법 |
| TW201120037A (en) * | 2009-10-26 | 2011-06-16 | Sunesis Pharmaceuticals Inc | Compounds and methods for treatment of cancer |
| WO2011056764A1 (en) | 2009-11-05 | 2011-05-12 | Ambit Biosciences Corp. | Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
| EP2499282B1 (en) | 2009-11-09 | 2015-04-22 | NeuroGenetic Pharmaceuticals, Inc. | Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor |
| US8528286B2 (en) * | 2009-11-10 | 2013-09-10 | Keene Building Products Co., Inc. | Sound control mat |
| US20110301235A1 (en) | 2009-12-02 | 2011-12-08 | Alquest Therapeutics, Inc. | Organoselenium compounds and uses thereof |
| MY159958A (en) | 2009-12-18 | 2017-02-15 | Idenix Pharmaceuticals Inc | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| SG181896A1 (en) * | 2009-12-23 | 2012-07-30 | Map Pharmaceuticals Inc | Novel ergoline analogs |
| WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| AU2011223873B2 (en) | 2010-03-02 | 2015-06-25 | Axikin Pharmaceuticals, Inc. | Isotopically enriched arylsulfonamide CCR3 antagonists |
| WO2011112689A2 (en) | 2010-03-11 | 2011-09-15 | Ambit Biosciences Corp. | Saltz of an indazolylpyrrolotriazine |
| MX336559B (es) | 2010-03-17 | 2016-01-25 | Axikin Pharmaceuticals Inc | Antagonistas de ccr3 de arilsulfonamida. |
| WO2011150201A2 (en) | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl amide compounds and methods of use thereof |
| WO2011150198A1 (en) | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl urea compounds and methods of use thereof |
| WO2011153197A1 (en) | 2010-06-01 | 2011-12-08 | Biotheryx, Inc. | Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases |
| AU2011261501B2 (en) | 2010-06-01 | 2016-01-21 | Biotheryx, Inc. | Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone |
| EP2576532B1 (en) | 2010-06-07 | 2018-07-18 | Novomedix, LLC | Furanyl compounds and the use thereof |
| WO2012012370A1 (en) | 2010-07-19 | 2012-01-26 | Summa Health System | Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| US8703943B2 (en) | 2010-09-01 | 2014-04-22 | Ambit Biosciences Corporation | Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
| EP2611809A1 (en) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | Azolopyridine and azolopyrimidine compounds and methods of use thereof |
| US20130317045A1 (en) | 2010-09-01 | 2013-11-28 | Ambit Biosciences Corporation | Thienopyridine and thienopyrimidine compounds and methods of use thereof |
| US20130225614A1 (en) | 2010-09-01 | 2013-08-29 | Ambit Biosciences Corporation | 4-azolylaminoquinazoline derivatives and methods of use thereof |
| WO2012030944A2 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | Quinoline and isoquinoline compounds and methods of use thereof |
| EP2611789A1 (en) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | Quinazoline compounds and methods of use thereof |
| US20130225578A1 (en) | 2010-09-01 | 2013-08-29 | Ambit Biosciences Corporation | 7-cyclylquinazoline derivatives and methods of use thereof |
| US20130225615A1 (en) | 2010-09-01 | 2013-08-29 | Ambit Biosciences Corporation | 2-cycloquinazoline derivatives and methods of use thereof |
| MX2013002383A (es) | 2010-09-01 | 2013-07-05 | Ambit Biosciences Corp | Sales bromhidrato de una pirazolilaminoquinazolina. |
| WO2012030918A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | Adenosine a3 receptor modulating compounds and methods of use thereof |
| WO2012044641A1 (en) | 2010-09-29 | 2012-04-05 | Pathway Therapeutics Inc. | 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| US20120088769A1 (en) | 2010-10-11 | 2012-04-12 | Axikin Pharmaceuticals, Inc. | Salts of arylsulfonamide ccr3 antagonists |
| US20120125711A1 (en) * | 2010-11-24 | 2012-05-24 | Stahr Richard E | Sound absorbing panel and system |
| JP2014500275A (ja) | 2010-12-06 | 2014-01-09 | フォリカ,インコーポレイテッド | 禿頭症を治療するため、および毛髪の成長を促進するための方法 |
| WO2012080050A1 (en) | 2010-12-14 | 2012-06-21 | F. Hoffmann-La Roche Ag | Solid forms of a phenoxybenzenesulfonyl compound |
| US20120189633A1 (en) | 2011-01-26 | 2012-07-26 | Kolltan Pharmaceuticals, Inc. | Anti-kit antibodies and uses thereof |
| JP2014503597A (ja) | 2011-01-31 | 2014-02-13 | セルジーン コーポレイション | シチジンアナログの医薬組成物及びその使用方法 |
| TW201309690A (zh) | 2011-02-10 | 2013-03-01 | Idenix Pharmaceuticals Inc | 巨環絲胺酸蛋白酶抑制劑,其醫藥組合物及其於治療hcv感染之用途 |
| CA2831590A1 (en) | 2011-03-28 | 2012-10-04 | Mei Pharma, Inc. | (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
| CN107501241B (zh) | 2011-03-28 | 2020-10-13 | 梅制药公司 | 化合物、含有其的药物组合物以及它们在治疗增生性疾病中的用途 |
| EP2691388A1 (en) | 2011-03-28 | 2014-02-05 | MEI Pharma, Inc. | (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
| US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
| KR20140042868A (ko) | 2011-06-23 | 2014-04-07 | 맵 파마슈티컬스, 인코포레이티드 | 신규한 플루오로에르골린 유사체 |
| WO2013037482A1 (en) | 2011-09-15 | 2013-03-21 | Phenex Pharmaceuticals Ag | Farnesoid x receptor agonists for cancer treatment and prevention |
| KR102066297B1 (ko) | 2011-10-14 | 2020-01-14 | 암비트 바이오사이언시즈 코포레이션 | 헤테로사이클릭 화합물 및 이의 유형 3 수용체 티로신 키나아제의 조절인자로서의 용도 |
| EP2793580A4 (en) | 2011-12-19 | 2015-05-20 | Map Pharmaceuticals Inc | NEW DERIVATIVES OF ISO-ERGOLINE |
| AU2012355983A1 (en) | 2011-12-21 | 2015-01-22 | Map Pharmaceuticals, Inc. | Novel neuromodulatory compounds |
| US9611253B2 (en) | 2012-02-29 | 2017-04-04 | Ambit Biosciences Corporation | Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith |
| CN104302640A (zh) | 2012-03-16 | 2015-01-21 | 埃克希金医药品有限公司 | 3,5-二氨基吡唑激酶抑制剂 |
| CA2871793C (en) | 2012-05-02 | 2020-09-15 | Pharmaxis Ltd. | Substituted 3-haloallylamine inhibitors of ssao and uses thereof |
| EP2861562B1 (en) | 2012-06-14 | 2018-05-09 | Mayo Foundation For Medical Education And Research | Pyrazole derivatives as inhibitors of stat3 |
| US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
| EP4063391A1 (en) | 2012-07-25 | 2022-09-28 | Celldex Therapeutics, Inc. | Anti-kit antibodies and uses thereof |
| US9074186B2 (en) | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
| BR112015004959A2 (pt) | 2012-09-07 | 2017-07-04 | Axikin Pharmaceuticals Inc | composto isotopicamente enriquecido, composição farmacêutica, método para tratar, prevenir ou amenizar um ou mais sintomas de uma doença, distúrbio ou condição mediada por ccr3, relacionada a eosinófilos, relacionada a basófilos, relacionada a mastócitos ou relacionada a mastócitos em um sujeito, método para tratar, prevenir ou amenizar um ou mais sintomas de uma doença inflamatória em um sujeito e método para modular a atividade de ccr3. |
| WO2014055647A1 (en) | 2012-10-03 | 2014-04-10 | Mei Pharma, Inc. | (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases |
| EP2916830A2 (en) | 2012-11-08 | 2015-09-16 | Summa Health System | Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing |
| WO2014085633A1 (en) | 2012-11-30 | 2014-06-05 | Novomedix, Llc | Substituted biaryl sulfonamides and the use thereof |
| AU2013361340A1 (en) | 2012-12-21 | 2015-07-09 | Map Pharmaceuticals, Inc. | Novel methysergide derivatives |
| US9169214B2 (en) | 2012-12-21 | 2015-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
| AU2014205324A1 (en) | 2013-01-11 | 2015-07-30 | Mayo Foundation For Medical Education And Research | Vitamins C and K for treating polycystic diseases |
| EP3003390B1 (en) | 2013-06-06 | 2021-07-07 | Pierre Fabre Médicament | Anti-c10orf54 antibodies and uses thereof |
| CA2917339C (en) * | 2013-07-07 | 2022-06-07 | 4Silence B.V. | Diffractor for diffracting sound |
| WO2015031613A1 (en) | 2013-08-30 | 2015-03-05 | Ambit Biosciences Corporation | Biaryl acetamide compounds and methods of use thereof |
| NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
| EP3046924A1 (en) | 2013-09-20 | 2016-07-27 | IDENIX Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
| EP3450571B1 (en) | 2014-02-24 | 2023-04-05 | Celgene Corporation | Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders |
| GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
| WO2015134560A1 (en) | 2014-03-05 | 2015-09-11 | Idenix Pharmaceuticals, Inc. | Solid forms of a flaviviridae virus inhibitor compound and salts thereof |
| IL291000B2 (en) | 2014-03-20 | 2024-04-01 | Capella Therapeutics Inc | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer |
| CA2943231C (en) | 2014-03-20 | 2023-10-24 | Capella Therapeutics, Inc. | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer |
| MX2016014731A (es) | 2014-05-12 | 2017-05-04 | Conatus Pharmaceuticals Inc | Tratamiento de las complicaciones de la enfermedad cronica del higado con enfermedades de caspasa. |
| JP6768639B2 (ja) | 2014-05-23 | 2020-10-21 | セルデックス セラピューティクス,インコーポレーテッド | 好酸球又はマスト細胞関連障害の治療 |
| LT3148579T (lt) | 2014-05-28 | 2021-05-25 | Agenus Inc. | Anti-gitr antikūnai ir jų panaudojimo būdai |
| WO2015195474A1 (en) | 2014-06-18 | 2015-12-23 | Biotheryx, Inc. | Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases |
| US9499514B2 (en) | 2014-07-11 | 2016-11-22 | Celgene Corporation | Antiproliferative compounds and methods of use thereof |
| US20160045609A1 (en) | 2014-08-14 | 2016-02-18 | Mamoun M. Alhamadsheh | Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life |
| AU2015314830B2 (en) | 2014-09-12 | 2021-01-07 | Tobira Therapeutics, Inc. | Cenicriviroc combination therapy for the treatment of fibrosis |
| US20170354639A1 (en) | 2014-10-24 | 2017-12-14 | Biogen Ma Inc. | Diterpenoid derivatives and methods of use thereof |
| EP3789039A1 (en) | 2014-12-22 | 2021-03-10 | The Rockefeller University | Anti-mertk agonistic antibodies and uses thereof |
| MY191736A (en) | 2014-12-23 | 2022-07-13 | Axikin Pharmaceuticals Inc | 3,5-diaminopyrazole kinase inhibitors |
| JP6856532B2 (ja) | 2015-01-20 | 2021-04-07 | エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc | エルゴリン化合物およびその使用 |
| WO2016119700A1 (en) | 2015-01-28 | 2016-08-04 | Jn Therapeutics | Substituted imidazo [1, 2-a] pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof |
| PL3265123T3 (pl) | 2015-03-03 | 2023-03-13 | Kymab Limited | Przeciwciała, zastosowania i sposoby |
| DK3303394T3 (da) | 2015-05-29 | 2020-07-06 | Agenus Inc | Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf |
| US20190015396A1 (en) | 2015-06-23 | 2019-01-17 | Neurocrine Biosciences, Inc. | Vmat2 inhibitors for treating neurological diseases or disorders |
| US11091559B2 (en) | 2015-08-27 | 2021-08-17 | Celldex Therapeutics, Inc. | Anti-ALK antibodies and methods for use thereof |
| JP6869987B2 (ja) | 2015-09-01 | 2021-05-12 | アジェナス インコーポレイテッド | 抗pd−1抗体及びその使用方法 |
| DK3368534T3 (da) | 2015-10-30 | 2021-02-15 | Neurocrine Biosciences Inc | Valbenazin-ditosylat og polymorfer deraf |
| WO2017079566A1 (en) | 2015-11-05 | 2017-05-11 | Conatus Pharmaceuticals, Inc. | Caspase inhibitors for use in the treatment of liver cancer |
| US10112924B2 (en) | 2015-12-02 | 2018-10-30 | Astraea Therapeutics, Inc. | Piperdinyl nociceptin receptor compounds |
| CN122562777A (zh) | 2015-12-02 | 2026-08-14 | 阿斯特来亚治疗有限责任公司 | 哌啶基痛敏肽受体化合物 |
| DK3394057T3 (da) | 2015-12-23 | 2022-04-11 | Neurocrine Biosciences Inc | Syntetisk fremgangsmåde til fremstilling af (S)-(2R,3R,11BR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11B-hexahydro-1H-pyrido[2,1,-A]isoquinolin-2-yl 2-amino-3-methylbutanoat-di(4-methylbenzensulfonat) |
| KR20180101418A (ko) | 2015-12-31 | 2018-09-12 | 코나터스 파마슈티칼스, 인크. | 간 질환의 치료에서의 카스파제 억제제의 사용 방법 |
| CA3010794A1 (en) | 2016-01-08 | 2017-07-13 | Celgene Corporation | Solid forms of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses |
| TWI782395B (zh) | 2016-01-08 | 2022-11-01 | 美商西建公司 | 抗增生化合物,及其醫藥組合物及用途 |
| US10960013B2 (en) | 2016-03-04 | 2021-03-30 | East Carolina University | J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders |
| WO2017156191A1 (en) | 2016-03-08 | 2017-09-14 | Los Gatos Pharmaceuticals, Inc. | Composite nanoparticles and uses thereof |
| WO2017156183A1 (en) | 2016-03-08 | 2017-09-14 | Los Gatos Pharmaceuticals, Inc. | Camptothecin derivatives and uses thereof |
| AU2017250086A1 (en) | 2016-04-11 | 2018-09-20 | Clexio Biosciences Ltd. | Deuterated ketamine derivatives |
| WO2017194789A1 (en) | 2016-05-13 | 2017-11-16 | Institut Pasteur | Inhibition of beta-2 nicotinic acetylcholine receptors to treat alzheimer's disease pathology |
| TWI753910B (zh) | 2016-05-16 | 2022-02-01 | 美商拜歐斯瑞克斯公司 | 吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途 |
| KR102543118B1 (ko) | 2016-05-27 | 2023-06-14 | 아게누스 인코포레이티드 | 항-tim-3 항체 및 이의 사용 방법 |
| DE102016111064A1 (de) * | 2016-06-16 | 2017-12-21 | Vossloh-Werke Gmbh | Elastisches Element für einen Befestigungspunkt für eine Schiene für Schienenfahrzeuge und Befestigungspunkt |
| CN106087611B (zh) * | 2016-06-20 | 2019-07-12 | 勾厚渝 | 轨道交通构件 |
| WO2018007999A1 (en) | 2016-07-08 | 2018-01-11 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
| WO2018035281A1 (en) | 2016-08-17 | 2018-02-22 | North Carolina State University | Northern-southern route to synthesis of bacteriochlorins |
| CN109982687A (zh) | 2016-09-19 | 2019-07-05 | 梅制药公司 | 联合疗法 |
| KR20230133934A (ko) | 2016-10-11 | 2023-09-19 | 아게누스 인코포레이티드 | 항-lag-3 항체 및 이의 사용 방법 |
| WO2018083248A1 (en) | 2016-11-03 | 2018-05-11 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses & methods |
| EP3535294B1 (en) | 2016-11-07 | 2025-02-12 | Neuracle Science Co., Ltd. | Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof |
| US10106521B2 (en) | 2016-11-09 | 2018-10-23 | Phloronol, Inc. | Eckol derivatives, methods of synthesis and uses thereof |
| CN110167542A (zh) | 2016-11-09 | 2019-08-23 | 诺沃梅迪科斯有限公司 | 1,1-二甲双胍的亚硝酸盐、药物组合物和使用方法 |
| US10836774B2 (en) | 2016-11-30 | 2020-11-17 | North Carolina State University | Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds |
| WO2018102455A1 (en) | 2016-12-01 | 2018-06-07 | Ignyta, Inc. | Methods for the treatment of cancer |
| TW202515564A (zh) | 2016-12-02 | 2025-04-16 | 美商紐羅克里生物科學有限公司 | 戊苯那嗪(valbenazine)於治療精神分裂症或情感性精神分裂症之用途 |
| CN110300599B (zh) | 2016-12-07 | 2024-07-02 | 艾吉纳斯公司 | 抗体和其使用方法 |
| IL307242B1 (en) | 2016-12-07 | 2026-07-01 | Agenus Inc | Anti-CTLA-4 antibodies and methods of using them |
| KR20230170136A (ko) | 2017-01-27 | 2023-12-18 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| EP3582798B1 (en) | 2017-02-17 | 2025-07-23 | DayLife LLC | Universal antivenom |
| EP3582773A4 (en) | 2017-02-17 | 2021-03-10 | Eidos Therapeutics, Inc. | PROCESS FOR THE MANUFACTURING OF AG-10, ITS INTERMEDIATES AND SALTS THEREOF |
| WO2018164996A1 (en) | 2017-03-06 | 2018-09-13 | Neurocrine Biosciences, Inc. | Dosing regimen for valbenazine |
| EP3601351A1 (en) | 2017-03-27 | 2020-02-05 | Celgene Corporation | Methods and compositions for reduction of immunogenicity |
| BR112019017241A2 (pt) | 2017-04-13 | 2020-04-14 | Agenus Inc. | anticorpos anti-cd137 e métodos de uso dos mesmos |
| WO2018193427A1 (en) | 2017-04-21 | 2018-10-25 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
| WO2018200605A1 (en) | 2017-04-26 | 2018-11-01 | Neurocrine Biosciences, Inc. | Use of valbenazine for treating levodopa-induced dyskinesia |
| LT3618863T (lt) | 2017-05-01 | 2023-10-10 | Agenus Inc. | Anti-tigit antikūnai ir jų panaudojimo būdai |
| JOP20190219A1 (ar) | 2017-05-09 | 2019-09-22 | Cardix Therapeutics LLC | تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية |
| US10085999B1 (en) | 2017-05-10 | 2018-10-02 | Arixa Pharmaceuticals, Inc. | Beta-lactamase inhibitors and uses thereof |
| JP7012384B2 (ja) | 2017-06-27 | 2022-02-14 | ニューラクル サイエンス カンパニー リミテッド | 癌治療のための抗fam19a5抗体の用途 |
| CN111344011B (zh) | 2017-06-27 | 2024-01-26 | 纽洛可科学有限公司 | 抗fam19a5抗体用于治疗纤维化的用途 |
| CN110972463B (zh) | 2017-06-27 | 2024-05-28 | 纽洛可科学有限公司 | 抗序列相似家族19成员a5抗体在治疗青光眼中的用途 |
| BR112019027729A2 (pt) | 2017-06-27 | 2020-08-18 | Neuracle Science Co., Ltd | anticorpos anti-fam19a5 e seus usos |
| US11571401B2 (en) | 2017-09-01 | 2023-02-07 | East Carolina University | Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response |
| CA3076000A1 (en) | 2017-09-21 | 2019-03-28 | Neurocrine Biosciences, Inc. | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| WO2019069229A1 (en) | 2017-10-02 | 2019-04-11 | Neuracle Science Co., Ltd. | USE OF ANTIBODIES DIRECTED AGAINST A SIMILARITY FAMILY OF SEQUENCE 19, ELEMENT A5, FOR THE TREATMENT AND DIAGNOSIS OF MOOD DISORDERS |
| KR20260033622A (ko) | 2017-10-04 | 2026-03-10 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 면역조절성 올리고사카라이드 |
| KR20250070134A (ko) | 2017-10-10 | 2025-05-20 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| US20200230127A1 (en) | 2017-10-10 | 2020-07-23 | Neurocrine Biosciences, Inc. | Methods for the Administration of Certain VMAT2 Inhibitors |
| CN111315772A (zh) | 2017-10-31 | 2020-06-19 | 斯塔顿生物技术有限公司 | 抗apoc3抗体及其使用方法 |
| WO2019139871A1 (en) | 2018-01-10 | 2019-07-18 | Cura Therapeutics Llc | Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications |
| AU2019207491A1 (en) | 2018-01-10 | 2020-07-30 | Cura Therapeutics, Llc | Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications |
| WO2019183463A1 (en) | 2018-03-23 | 2019-09-26 | Eidos Therapeutics, Inc. | Methods of treating ttr amyloidosis using ag10 |
| KR102866162B1 (ko) | 2018-04-24 | 2025-10-01 | 주식회사 뉴라클사이언스 | 신경병성 통증의 치료를 위한 서열 유사성 19, 멤버 a5 항체를 갖는 항-패밀리의 용도 |
| KR20240056644A (ko) | 2018-05-10 | 2024-04-30 | 주식회사 뉴라클사이언스 | 서열 유사성 19, 멤버 a5 항체를 갖는 항-패밀리 및 그의 사용 방법 |
| JOP20200298A1 (ar) | 2018-06-14 | 2020-11-22 | Neurocrine Biosciences Inc | مركبات مثبطة لـ vmat2 وتركيبات وطرق تتعلق بها |
| CN108836091B (zh) * | 2018-06-27 | 2020-12-04 | 贵州筑信达创科技有限公司 | 导轨 |
| CN108533609B (zh) * | 2018-06-27 | 2020-03-10 | 贵州筑信达创科技有限公司 | 导轨及滑动件的组合结构 |
| US11447497B2 (en) | 2018-06-29 | 2022-09-20 | Histogen, Inc. | (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases |
| KR20250024129A (ko) | 2018-07-20 | 2025-02-18 | 피에르 파브르 메디카먼트 | Vista의 수용체 |
| SG11202100303QA (en) | 2018-08-15 | 2021-02-25 | Neurocrine Biosciences Inc | Methods for the administration of certain vmat2 inhibitors |
| LT3836920T (lt) | 2018-08-17 | 2026-01-26 | Eidos Therapeutics, Inc. | Ag10 farmacinės formos |
| JP2022504287A (ja) | 2018-10-03 | 2022-01-13 | スターテン・バイオテクノロジー・ベー・フェー | ヒト及びカニクイザルapoc3に特異的な抗体、並びにその使用の方法 |
| KR102648762B1 (ko) | 2018-10-16 | 2024-03-19 | 주식회사 뉴라클사이언스 | 항-fam19a5 항체의 용도 |
| CA3119341A1 (en) | 2018-11-16 | 2020-05-22 | Neoimmunetech, Inc. | Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor |
| WO2020118042A1 (en) | 2018-12-05 | 2020-06-11 | Jacobs Wagner Christine | Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies |
| KR20200071198A (ko) | 2018-12-10 | 2020-06-19 | 네오이뮨텍, 인코퍼레이티드 | Nrf2 발현 조절 기반 T 세포 항암면역치료법 |
| JP7407461B2 (ja) | 2018-12-19 | 2024-01-04 | シャイ・セラピューティクス・エルエルシー | がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物 |
| KR20240000655A (ko) | 2018-12-27 | 2024-01-02 | 주식회사 뉴라클사이언스 | 죽상경화증을 치료하기 위한 항-fam19a5 항체의 사용 |
| MX2021004504A (es) | 2019-01-02 | 2021-10-01 | Neuracle Science Co Ltd | Anti-familia con similitud de secuencia 19, anticuerpos del miembro a5 y método de uso de los mismos. |
| CN113874080B (zh) | 2019-02-06 | 2024-09-27 | 戴斯阿尔法公司 | Il-17a调节剂及其用途 |
| CN119735688A (zh) | 2019-02-26 | 2025-04-01 | 茵思博纳公司 | 高-亲和力抗-mertk抗体及其用途 |
| AU2020231396B2 (en) | 2019-03-07 | 2025-03-20 | Nobo Medicine Inc. | Caspase inhibitors and methods of use thereof |
| US20220249707A1 (en) | 2019-05-20 | 2022-08-11 | Nirvana Sciences Inc. | Narrow emission dyes, compositions comprising same, and methods for making and using same |
| JP7853099B2 (ja) | 2019-05-20 | 2026-04-28 | ニルバナ サイエンシーズ インク. | 発光波長の範囲が狭い発光染料、それを含む組成物及びそれを製造及び使用する方法 |
| WO2021007478A1 (en) | 2019-07-11 | 2021-01-14 | Cura Therapeutics, Llc | Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases |
| EP3996813A1 (en) | 2019-07-11 | 2022-05-18 | Cura Therapeutics, LLC | Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications |
| US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| CN114585644A (zh) | 2019-08-30 | 2022-06-03 | 艾吉纳斯公司 | 抗cd96抗体及其使用方法 |
| JP7566889B2 (ja) | 2019-09-16 | 2024-10-15 | ダイス・アルファ・インコーポレイテッド | Il-17aモジュレーターおよびその使用 |
| KR102337657B1 (ko) * | 2019-11-06 | 2021-12-09 | 한국철도기술연구원 | 철도진동저감용 조립식 블록 및 이를 이용한 블록 구조물 |
| AU2021207586A1 (en) | 2020-01-13 | 2022-07-21 | Neoimmunetech, Inc. | Method of treating a tumor with a combination of IL-7 protein and a bispecific antibody |
| CN113136745B (zh) * | 2020-01-17 | 2024-10-25 | 洛阳双瑞橡塑科技有限公司 | 一种轨道道床吸音减振装置 |
| EP4093751A1 (en) | 2020-01-22 | 2022-11-30 | Outpace Bio, Inc. | Chimeric polypeptides |
| AU2021217373A1 (en) | 2020-02-05 | 2022-08-04 | Neoimmunetech, Inc. | Method of treating a solid tumor with a combination of an IL-7 protein and CAR-bearing immune cells |
| US12006643B2 (en) * | 2020-05-27 | 2024-06-11 | Mute Wall Systems, Inc. | Sound dampening barrier wall |
| CA3179635A1 (en) | 2020-05-29 | 2021-12-02 | Boulder Bioscience Llc | Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane |
| US20230227466A1 (en) | 2020-06-18 | 2023-07-20 | Shy Therapeutics, Llc | Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| US12024521B2 (en) | 2020-06-30 | 2024-07-02 | Prosetta Biosciences, Inc. | Isoquinoline derivatives, methods of synthesis and uses thereof |
| US20240025863A1 (en) | 2020-09-16 | 2024-01-25 | Biotheryx, Inc. | Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| TW202231269A (zh) | 2020-10-23 | 2022-08-16 | 美商拜歐斯瑞克斯公司 | Kras蛋白降解劑、其醫藥組合物及其治療應用 |
| KR20230104176A (ko) | 2020-11-02 | 2023-07-07 | 네오이뮨텍, 인코퍼레이티드 | 코로나바이러스의 치료를 위한 인터류킨-7의 용도 |
| JP2023549112A (ja) | 2020-11-05 | 2023-11-22 | ネオイミューンテック, インコーポレイテッド | Il-7タンパク質とヌクレオチドワクチンの組み合わせで腫瘍を治療する方法 |
| CN112712784B (zh) * | 2020-11-30 | 2024-12-31 | 南京华秦光声科技有限责任公司 | 一种低频宽带平板吸声结构 |
| US20240124418A1 (en) | 2020-12-14 | 2024-04-18 | Biotheryx, Inc. | Pde4 degraders, pharmaceutical compositions, and therapeutic applications |
| WO2022165000A1 (en) | 2021-01-27 | 2022-08-04 | Shy Therapeutics, Llc | Methods for the treatment of fibrotic disease |
| US20240124483A1 (en) | 2021-01-27 | 2024-04-18 | Shy Therapeutics, Llc | Methods for the Treatment of Fibrotic Disease |
| IL305752A (en) | 2021-03-10 | 2023-11-01 | Dice Molecules Sv Inc | INTEGRIN INHIBITORS OF ALPHA V BETA 6 AND ALPHA V BETA 1 AND THEIR USES |
| WO2022226166A1 (en) | 2021-04-22 | 2022-10-27 | Protego Biopharma, Inc. | Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosis |
| WO2022251533A1 (en) | 2021-05-27 | 2022-12-01 | Protego Biopharma, Inc. | Heteroaryl diamide ire1/xbp1s activators |
| KR20240028362A (ko) | 2021-05-28 | 2024-03-05 | 라이엘 이뮤노파마, 인크. | Nr4a3-결핍 면역 세포 및 이의 용도 |
| KR20240027676A (ko) | 2021-06-02 | 2024-03-04 | 라이엘 이뮤노파마, 인크. | Nr4a3-결핍 면역 세포 및 이의 용도 |
| CA3218481A1 (en) | 2021-06-14 | 2022-12-22 | argenx BV | Anti-il-9 antibodies and methods of use thereof |
| WO2022266249A1 (en) | 2021-06-16 | 2022-12-22 | Biotheryx, Inc. | Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| JP2024522768A (ja) | 2021-06-16 | 2024-06-21 | バイオセリックス, インコーポレイテッド | Sos1タンパク質分解剤、その医薬組成物及びそれらの治療的応用 |
| US20240277857A1 (en) | 2021-09-29 | 2024-08-22 | Nbios, Inc. | Coiled-coil fusion protein |
| CA3236150A1 (en) | 2021-10-22 | 2023-04-27 | Prosetta Biosciences, Inc. | Novel host-targeted pan-respiratory antiviral small molecule therapeutics |
| US20250129067A1 (en) | 2021-11-08 | 2025-04-24 | Progentos Therapeutics, Inc. | Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof |
| CN119836296A (zh) | 2021-12-30 | 2025-04-15 | 新免疫技术有限公司 | 用il-7蛋白和vegf拮抗剂的组合治疗肿瘤的方法 |
| WO2023129577A1 (en) | 2022-01-03 | 2023-07-06 | Lilac Therapeutics, Inc. | Cyclic thiol prodrugs |
| EP4433040A4 (en) | 2022-01-03 | 2025-11-12 | Lilac Therapeutics Inc | ACYCLIC THIOL PRODRUGS |
| CA3252183A1 (en) | 2022-01-18 | 2023-07-27 | IC-MedTech Corp. | BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS |
| CA3251592A1 (en) | 2022-02-17 | 2025-07-09 | Novelty Nobility Inc. | ANTIBODY-DRUG CONJUGATE |
| JP2025507621A (ja) | 2022-03-02 | 2025-03-21 | ミトパワー, インク. | ニコチン酸及びリボースから誘導体化した新規プロドラッグ |
| AU2023245901A1 (en) | 2022-03-30 | 2024-10-03 | Biomarin Pharmaceutical Inc. | Dystrophin exon skipping oligonucleotides |
| GB2619907A (en) | 2022-04-01 | 2023-12-27 | Kanna Health Ltd | Novel crystalline salt forms of mesembrine |
| EP4508044A1 (en) | 2022-04-14 | 2025-02-19 | Bristol-Myers Squibb Company | Novel gspt1 compounds and methods of use of the novel compounds |
| EP4519439A1 (en) | 2022-05-05 | 2025-03-12 | BioMarin Pharmaceutical Inc. | Method of treating duchenne muscular dystrophy |
| TW202413356A (zh) | 2022-05-10 | 2024-04-01 | 美商拜歐斯瑞克斯公司 | Cdk蛋白降解劑、藥物組合物及其治療應用 |
| US20260083846A1 (en) | 2022-05-19 | 2026-03-26 | Lyell Immunopharma, Inc. | Polynucleotides targeting nr4a3 and uses thereof |
| JP2025531869A (ja) | 2022-09-09 | 2025-09-25 | イノヴォ セラピューティクス、インコーポレイテッド | CK1αおよびDUAL CK1α/GSPT1分解化合物 |
| WO2024073473A1 (en) | 2022-09-30 | 2024-04-04 | Boulder Bioscience Llc | Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury |
| AU2023364731A1 (en) | 2022-10-21 | 2025-04-03 | Diagonal Therapeutics Inc. | Heteromeric agonistic antibodies to il-18 receptor |
| WO2024092037A1 (en) | 2022-10-26 | 2024-05-02 | Protego Biopharma, Inc. | Spirocycle containing pyridone compounds |
| EP4608834A1 (en) | 2022-10-26 | 2025-09-03 | Protego Biopharma, Inc. | Spirocycle containing pyridine compounds |
| EP4608839A1 (en) | 2022-10-26 | 2025-09-03 | Protego Biopharma, Inc. | Spirocycle containing bicyclic heteroaryl compounds |
| JP2026504619A (ja) | 2022-11-07 | 2026-02-06 | ネオイミューンテック, インコーポレイテッド | 非メチル化mgmtプロモーターを含む腫瘍を治療する方法 |
| EP4626865A1 (en) | 2022-11-30 | 2025-10-08 | Protego Biopharma, Inc. | Cyclic pyrazole diamide ire1/xbp1s activators |
| US20260193236A1 (en) | 2022-11-30 | 2026-07-09 | Protego Biopharma, Inc. | Linear heteroaryl diamide ire1/xbp1s activators |
| KR102870410B1 (ko) * | 2022-12-09 | 2025-10-16 | 한국전자기술연구원 | 방음재 및 소음 제어 시스템 |
| WO2024194685A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
| WO2024194686A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
| US20250002588A1 (en) | 2023-04-07 | 2025-01-02 | Diagonal Therapeutics Inc. | Bispecific agonistic antibodies to activin a receptor like type 1 (alk1) |
| CN121057752A (zh) | 2023-04-07 | 2025-12-02 | 达科纳治疗有限公司 | 铰链经修饰的双特异性抗体 |
| JP2026516311A (ja) | 2023-04-24 | 2026-05-21 | バイオマリン ファーマシューティカル インコーポレイテッド | Stxbp1障害を治療するための組成物および方法 |
| WO2024233303A1 (en) | 2023-05-05 | 2024-11-14 | Biomarin Pharmaceutical Inc. | Dystrophin exon skipping oligonucleotides |
| WO2024233642A1 (en) | 2023-05-09 | 2024-11-14 | Progentos Therapeutics, Inc. | Heterocyclic compounds and uses thereof |
| EP4687888A2 (en) | 2023-05-16 | 2026-02-11 | Lilac Therapeutics, Inc. | Phenol prodrugs |
| WO2024243048A1 (en) | 2023-05-19 | 2024-11-28 | Diagonal Therapeutics Inc. | Bispecific agonistic antibodies to il12 receptor |
| CN121729432A (zh) | 2023-06-23 | 2026-03-24 | 派克西斯肿瘤学公司 | 抗klrg1抗体及其用途 |
| KR20260033048A (ko) | 2023-07-03 | 2026-03-10 | 네오이뮨텍, 인코퍼레이티드 | 이종이합체 fc 분자 및 이의 용도 |
| WO2025046298A2 (en) | 2023-09-01 | 2025-03-06 | iTeos Belgium SA | Anti-trem2 antibodies and methods of use |
| AU2024344247A1 (en) | 2023-09-19 | 2026-05-07 | Kancure Pte. Ltd. | Survivin-targeted compounds |
| CN122003411A (zh) | 2023-09-27 | 2026-05-08 | 爱索斯特里克斯公司 | Myst抑制剂 |
| KR20260094777A (ko) | 2023-10-16 | 2026-06-23 | 브리스톨-마이어스 스큅 컴퍼니 | Gspt1 화합물 및 상기 화합물의 사용 방법 |
| IL327756A (en) | 2023-10-23 | 2026-06-01 | Diagonal Therapeutics Inc | Heteromeric agonistic antibodies to il-18 receptor |
| GB2636969A (en) | 2023-11-24 | 2025-07-09 | Ontrack Therapeutics Ltd | Novel crystalline salt forms |
| AU2024403128A1 (en) | 2023-12-19 | 2026-06-25 | Vectory Therapeutics B.V. | Anti-tdp-43 antibodies and uses thereof |
| AU2025206198A1 (en) | 2024-01-04 | 2026-07-23 | Innovo Therapeutics, Inc. | Compositions and methods for degrading aryl hydrocarbon receptor nuclear translocator protein |
| WO2025179161A1 (en) | 2024-02-21 | 2025-08-28 | Innovo Therapeutics, Inc. | Protein degrading compounds |
| WO2025201633A1 (en) | 2024-03-26 | 2025-10-02 | Chen Gefei | An agent for reducing amyloid formation |
| WO2025255341A1 (en) | 2024-06-05 | 2025-12-11 | Protego Biopharma, Inc. | Tetrahydrofuranyl ire1/xbp1s activators |
| WO2026080752A2 (en) | 2024-10-09 | 2026-04-16 | Diagonal Therapeutics Inc. | De novo antibodies to activin a receptor like type 1 (alk1) |
| WO2026080757A2 (en) | 2024-10-09 | 2026-04-16 | Diagonal Therapeutics Inc. | Activin receptor type ii a/b (actriia/b) antibodies |
| US20260234273A1 (en) | 2024-10-09 | 2026-08-13 | Diagonal Therapeutics Inc. | Bone morphogenetic protein receptor type 2 (bmprii) antibodies |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2350759A1 (de) * | 1973-10-10 | 1975-04-24 | Straetner Geb Buss Anita | Abdeckplatte fuer gleisanlagen |
| DE3602313A1 (de) * | 1986-01-27 | 1987-07-30 | Clouth Gummiwerke Ag | Schallabsorbierender laermschutz insbesondere fuer schotterlose gleise |
| DE4243102A1 (en) * | 1991-12-20 | 1993-07-01 | Bold Karl Gmbh & Co | Noise protection and sight wall with carrier girder construction |
| DE29515935U1 (de) * | 1995-10-07 | 1995-11-30 | Deutsche Asphalt GmbH, 63263 Neu-Isenburg | Schallabsorber für einen schotterlosen Eisenbahnoberbau |
| NL9400910A (nl) * | 1994-06-06 | 1996-01-02 | Veldhoen Raalte B V | Samenstel voor de geluidsisolatie van een spoorbaan. |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3991848A (en) * | 1974-08-16 | 1976-11-16 | Frigitemp | Acoustical board |
| US4142468A (en) * | 1976-04-20 | 1979-03-06 | Charles Birnstiel | Elevated rail transit guideway with noise attenuators |
| US4093120A (en) | 1977-01-24 | 1978-06-06 | Park Rubber Company | Railroad crossing structure |
| DE7711191U1 (de) | 1977-04-07 | 1978-09-28 | Straetner Geb. Buss, Anita, 4300 Essen | Fahrbahnplatte fuer schienengleiche bahnuebergaenge |
| DE7719283U1 (de) | 1977-06-20 | 1977-10-27 | Gummiwerk Kraiburg Gmbh & Co, 8264 Waldkraiburg | Platte fuer schienengleiche bahnuebergaenge |
| DE3827547C2 (de) * | 1988-08-13 | 2000-09-21 | Zueblin Ag | Schallabsorptionskonstruktion für schotterlose Eisenbahnoberbauten |
| US4960184A (en) * | 1989-11-09 | 1990-10-02 | Bruce Woodward | Sound absorbing structure |
| ATE158625T1 (de) * | 1994-02-11 | 1997-10-15 | Autostrade Concess Const | Schalldämpfender strassenbelag und verfahren zu dessen herstellung |
| DE4414566C2 (de) * | 1994-04-27 | 1997-11-20 | Freudenberg Carl Fa | Luftschalldämpfer |
| DE4417402A1 (de) | 1994-05-18 | 1995-11-23 | Gruenzweig & Hartmann Montage | Schallschutzeinrichtung zur Schalldämpfung und -dämmung an Gleiskörpern |
| IT1293307B1 (it) * | 1997-07-09 | 1999-02-16 | Dieselbox Sa | Barriera antirumore a pannelli trasparenti,dotata di caratteristiche fonoisolanti e fonoassorbenti |
-
1997
- 1997-05-19 TW TW086106684A patent/TW345603B/zh not_active IP Right Cessation
- 1997-05-23 DK DK97922748T patent/DK0901536T3/da active
- 1997-05-23 EP EP97922748A patent/EP0901536B1/de not_active Expired - Lifetime
- 1997-05-23 AU AU28801/97A patent/AU738889B2/en not_active Ceased
- 1997-05-23 CA CA002255946A patent/CA2255946C/en not_active Expired - Fee Related
- 1997-05-23 DE DE59708955T patent/DE59708955D1/de not_active Expired - Lifetime
- 1997-05-23 ES ES97922748T patent/ES2186891T3/es not_active Expired - Lifetime
- 1997-05-23 WO PCT/AT1997/000109 patent/WO1997045592A1/de not_active Ceased
- 1997-05-23 US US09/194,505 patent/US6253872B1/en not_active Expired - Lifetime
- 1997-05-23 CN CNB971950490A patent/CN100424268C/zh not_active Expired - Fee Related
- 1997-05-23 JP JP54125697A patent/JP3822641B2/ja not_active Expired - Fee Related
- 1997-05-23 AT AT97922748T patent/ATE229595T1/de active
- 1997-05-23 HU HU9903612A patent/HU221872B1/hu not_active IP Right Cessation
-
1998
- 1998-11-30 NO NO19985600A patent/NO316078B1/no not_active IP Right Cessation
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2350759A1 (de) * | 1973-10-10 | 1975-04-24 | Straetner Geb Buss Anita | Abdeckplatte fuer gleisanlagen |
| DE3602313A1 (de) * | 1986-01-27 | 1987-07-30 | Clouth Gummiwerke Ag | Schallabsorbierender laermschutz insbesondere fuer schotterlose gleise |
| DE4243102A1 (en) * | 1991-12-20 | 1993-07-01 | Bold Karl Gmbh & Co | Noise protection and sight wall with carrier girder construction |
| NL9400910A (nl) * | 1994-06-06 | 1996-01-02 | Veldhoen Raalte B V | Samenstel voor de geluidsisolatie van een spoorbaan. |
| DE29515935U1 (de) * | 1995-10-07 | 1995-11-30 | Deutsche Asphalt GmbH, 63263 Neu-Isenburg | Schallabsorber für einen schotterlosen Eisenbahnoberbau |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0945547A1 (de) * | 1998-03-21 | 1999-09-29 | Johann Rath | Vorrichtung zur Dämpfung von Schallemissionen an Gleisanlagen |
| DE19812481A1 (de) * | 1998-03-21 | 1999-09-30 | Johann Rath | Vorrichtung zur Dämpfung von Schallemissionen an Gleisanlagen |
| WO1999049134A1 (de) * | 1998-03-21 | 1999-09-30 | Johann Rath | Vorrichtung zur dämpfung von schallemissionen an gleisanlagen |
| DE19812481C2 (de) * | 1998-03-21 | 2002-08-22 | Johann Rath | Vorrichtung zur Dämpfung von Schallemissionen an Gleisanlagen |
| EP1039032A1 (de) * | 1999-03-26 | 2000-09-27 | DVG Deutsche Verpackungsmittel-GmbH | Absorptionsbelag zur Reduzierung der Schallabstrahlung für Gleiskörper |
| US6481637B1 (en) * | 2000-11-20 | 2002-11-19 | Mcqueen Philip Jeffrey | Rail pad and method for strain attentuation |
| WO2005085529A1 (de) * | 2004-03-05 | 2005-09-15 | Gmundner Fertigteile Gesellschaft M.B.H. & Co. Kg. | Störschall mindernde gleiseindeckung |
| AU2005219446B2 (en) * | 2004-03-05 | 2010-11-11 | Gmundner Fertigteile Gesellschaft M.B.H. & Co. Kg | Noise reducing track covering |
| NL2003697C2 (nl) * | 2009-10-22 | 2011-04-26 | Univ Twente | Weg met geluid-diffractoren. |
| WO2011049454A2 (en) | 2009-10-22 | 2011-04-28 | Universiteit Twente | Road with sound diffractors |
| WO2011049454A3 (en) * | 2009-10-22 | 2012-05-18 | Universiteit Twente | Road with sound diffractors |
| US8696233B2 (en) | 2009-10-22 | 2014-04-15 | 4Silence B.V. | Road with sound diffractors |
Also Published As
| Publication number | Publication date |
|---|---|
| NO985600D0 (no) | 1998-11-30 |
| EP0901536B1 (de) | 2002-12-11 |
| NO985600L (no) | 1998-11-30 |
| EP0901536A1 (de) | 1999-03-17 |
| DK0901536T3 (da) | 2003-04-07 |
| HUP9903612A3 (en) | 2001-08-28 |
| US6253872B1 (en) | 2001-07-03 |
| JP2000510921A (ja) | 2000-08-22 |
| HUP9903612A2 (hu) | 2000-02-28 |
| CA2255946C (en) | 2006-03-14 |
| TW345603B (en) | 1998-11-21 |
| CN1219989A (zh) | 1999-06-16 |
| ATE229595T1 (de) | 2002-12-15 |
| DE59708955D1 (de) | 2003-01-23 |
| NO316078B1 (no) | 2003-12-08 |
| HU221872B1 (hu) | 2003-02-28 |
| JP3822641B2 (ja) | 2006-09-20 |
| AU2880197A (en) | 1998-01-05 |
| CN100424268C (zh) | 2008-10-08 |
| AU738889B2 (en) | 2001-09-27 |
| CA2255946A1 (en) | 1997-12-04 |
| ES2186891T3 (es) | 2003-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0901536B1 (de) | Schallschutzeinrichtung für gleise | |
| EP0904461B1 (de) | Schienengleiche eindeckung für gleise | |
| DE2537408C3 (de) | Baustein zur Herstellung einer bepflanzbaren Stützmauer | |
| WO2013075159A1 (de) | Lärmschutzvorrichtung | |
| EP0214524B1 (de) | Mauerwerk- oder Pflasterstein aus Beton oder dergleichen | |
| EP0149697A1 (de) | Fugenabdeckung für Dehnungsfugen in Verkehrswegen, insbesondere Brücken | |
| DE4430769C2 (de) | Eisenbahnoberbau mit einem auf einer durchgehenden Tragplatte aus Stahlbeton aufgelagerten Gleisrost | |
| DE3134473A1 (de) | Schotterloser oberbau fuer schienenbahnen | |
| DE102007037339A1 (de) | Gabionenkorb mit lärmdämmender, monolithischer Schicht aus Beton | |
| DE3827547C2 (de) | Schallabsorptionskonstruktion für schotterlose Eisenbahnoberbauten | |
| DE29515935U1 (de) | Schallabsorber für einen schotterlosen Eisenbahnoberbau | |
| DE202011052057U1 (de) | Lärmschutzvorrichtung | |
| DE19514458A1 (de) | Schallabsorbierendes Wandelement | |
| EP2817456B1 (de) | Lärmschutzvorrichtung | |
| DE3544481A1 (de) | Schallschutzwand und dafuer geeignetes wandelement | |
| AT403809B (de) | Schallschutzeinrichtung für gleise | |
| EP1721045B1 (de) | Störschall mindernde gleiseindeckung | |
| DE8717982U1 (de) | Schallabsorbierendes Bauelement | |
| DE19540357C1 (de) | Eisenbahnbrücke und Kulisse zur Schalldämpfung an dieser | |
| DE19635788A1 (de) | Schalldämpfungselement für Schienentrassen mit fester Fahrbahn | |
| EP1136622B1 (de) | Gleiseindeckung | |
| EP0166719A2 (de) | Profildichtung | |
| AT512391B1 (de) | Lärmschutzvorrichtung | |
| DE2856367A1 (de) | Plattenbelag fuer daecher sowie tragelemente fuer diese | |
| DE2607538A1 (de) | Verbundformsteinelement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 97195049.0 Country of ref document: CN |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| ENP | Entry into the national phase |
Ref document number: 2255946 Country of ref document: CA Ref document number: 2255946 Country of ref document: CA Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09194505 Country of ref document: US |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1997922748 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 1997 9070 Country of ref document: AT Date of ref document: 19971204 Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 19979070 Country of ref document: AT |
|
| WWP | Wipo information: published in national office |
Ref document number: 1997922748 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1997922748 Country of ref document: EP |